Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Impact of diet and exercise on lipid management in the modern era.

Franklin BA, Durstine JL, Roberts CK, Barnard RJ.

Best Pract Res Clin Endocrinol Metab. 2014 Jun;28(3):405-21. doi: 10.1016/j.beem.2014.01.005. Epub 2014 Jan 22. Review.

PMID:
24840267
2.

HDL and lifestyle interventions.

Escolà-Gil JC, Julve J, Griffin BA, Freeman D, Blanco-Vaca F.

Handb Exp Pharmacol. 2015;224:569-92. doi: 10.1007/978-3-319-09665-0_18. Review.

PMID:
25523002
3.

[Cardiovascular risk factors and prevention in women: similarities and differences].

Sclavo M.

Ital Heart J Suppl. 2001 Feb;2(2):125-41. Review. Italian.

PMID:
11255880
4.

Pathogenesis and management of the dyslipidemia of the metabolic syndrome.

Raal FJ.

Metab Syndr Relat Disord. 2009 Apr;7(2):83-8. doi: 10.1089/met.2008.0079. Review.

PMID:
19400742
5.

Waging war on modern chronic diseases: primary prevention through exercise biology.

Booth FW, Gordon SE, Carlson CJ, Hamilton MT.

J Appl Physiol (1985). 2000 Feb;88(2):774-87. Review.

PMID:
10658050
6.

Persistence of uncontrolled cardiovascular risk factors in patients treated with percutaneous interventions for stable coronary artery disease not receiving cardiac rehabilitation.

Khattab AA, Knecht M, Meier B, Windecker S, Schmid JP, Wilhelm M, Saner H.

Eur J Prev Cardiol. 2013 Oct;20(5):743-9. doi: 10.1177/2047487312447751. Epub 2012 Apr 30.

PMID:
22547410
7.

Prevention of coronary heart disease. Part I. Primary prevention.

Liebson PR, Amsterdam EA.

Dis Mon. 1999 Dec;45(12):497-571. Review.

PMID:
10711300
8.

Dyslipidemia: management using optimal lipid-lowering therapy.

Ito MK.

Ann Pharmacother. 2012 Oct;46(10):1368-81. doi: 10.1345/aph.1R127. Epub 2012 Oct 2. Review.

PMID:
23032652
9.
10.

Cardiac Rehabilitation: Underrecognized/Underutilized.

Franklin BA, Brinks J.

Curr Treat Options Cardiovasc Med. 2015 Dec;17(12):62. doi: 10.1007/s11936-015-0422-x.

PMID:
26526338
11.

The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.

Cardenas GA, Lavie CJ, Cardenas V, Milani RV, McCullough PA.

Rev Cardiovasc Med. 2008 Fall;9(4):239-58. Review.

PMID:
19122582
13.

Managing the lipid profile of coronary heart disease patients.

Drakopoulou M, Toutouzas K, Stathogiannis K, Synetos A, Trantalis G, Tousoulis D.

Expert Rev Cardiovasc Ther. 2016 Nov;14(11):1263-1271. doi: 10.1080/14779072.2016.1221341. Epub 2016 Aug 23. Review.

PMID:
27552726
14.

Dyslipidemia in the metabolic syndrome in children.

Gidding SS.

J Cardiometab Syndr. 2006 Summer;1(4):282-5. Review.

15.

Mini review: physical activity and fitness and its relations to cardiovascular disease risk factors in children.

Froberg K, Andersen LB.

Int J Obes (Lond). 2005 Sep;29 Suppl 2:S34-9. Review.

PMID:
16385750
16.

Exercise and diet, independent of weight loss, improve cardiometabolic risk profile in overweight and obese individuals.

Gaesser GA, Angadi SS, Sawyer BJ.

Phys Sportsmed. 2011 May;39(2):87-97. doi: 10.3810/psm.2011.05.1898. Review.

PMID:
21673488
17.

Healthy lifestyles and cardiovascular risk profiles in young Australian adults: the Childhood Determinants of Adult Health Study.

Gall SL, Jamrozik K, Blizzard L, Dwyer T, Venn A.

Eur J Cardiovasc Prev Rehabil. 2009 Dec;16(6):684-9. doi: 10.1097/HJR.0b013e3283315888.

PMID:
19734791
18.
19.
20.

[Low HDL-cholesterol--an important risk factor for cardiovascular diseases].

Reiner Z, Muacević-Katanec D, Katanec D, Tedeschi-Reiner E.

Lijec Vjesn. 2011 Mar-Apr;133(3-4):111-6. Review. Croatian.

PMID:
21612108

Supplemental Content

Support Center